|
|
Blood, 15 December 2008, Vol. 112, No. 13, pp. 4793-4807.
Previous Article | Table of Contents | Next Article 
ASH 50TH ANNIVERSARY REVIEW
Stem cell concepts renew cancer research
John E. Dick1
1 Division of Cell and Molecular Biology, University Health Network, and Department of Molecular Genetics, University of Toronto, Toronto, ON
Although uncontrolled proliferation is a distinguishing property of a tumor as a whole, the individual cells that make up the tumor exhibit considerable variation in many properties, including morphology, proliferation kinetics, and the ability to initiate tumor growth in transplant assays. Understanding the molecular and cellular basis of this heterogeneity has important implications in the design of therapeutic strategies. The mechanistic basis of tumor heterogeneity has been uncertain; however, there is now strong evidence that cancer is a cellular hierarchy with cancer stem cells at the apex. This review provides a historical overview of the influence of hematology on the development of stem cell concepts and their linkage to cancer.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D Mullassery, C Dominici, E C Jesudason, H P McDowell, and P D Losty
Neuroblastoma: contemporary management
Arch. Dis. Child. Ed. Pract.,
December 1, 2009;
94(6):
177 - 185.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Milsom, N. Magnus, B. Meehan, K. Al-Nedawi, D. Garnier, and J. Rak
Tissue Factor and Cancer Stem Cells: Is There a Linkage?
Arterioscler Thromb Vasc Biol,
December 1, 2009;
29(12):
2005 - 2014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tefferi and J. W. Vardiman
Myelodysplastic Syndromes
N. Engl. J. Med.,
November 5, 2009;
361(19):
1872 - 1885.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Heuser, L. M. Sly, B. Argiropoulos, F. Kuchenbauer, C. Lai, A. Weng, M. Leung, G. Lin, C. Brookes, S. Fung, et al.
Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal
Blood,
November 5, 2009;
114(19):
3983 - 3993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Creighton, X. Li, M. Landis, J. M. Dixon, V. M. Neumeister, A. Sjolund, D. L. Rimm, H. Wong, A. Rodriguez, J. I. Herschkowitz, et al.
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
PNAS,
August 18, 2009;
106(33):
13820 - 13825.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. P. Levings, S. V. McGarry, T. P. Currie, D. M. Nickerson, S. McClellan, S. C. Ghivizzani, D. A. Steindler, and C. P. Gibbs
Expression of an Exogenous Human Oct-4 Promoter Identifies Tumor-Initiating Cells in Osteosarcoma
Cancer Res.,
July 15, 2009;
69(14):
5648 - 5655.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Rosen and C. T. Jordan
The Increasing Complexity of the Cancer Stem Cell Paradigm
Science,
June 26, 2009;
324(5935):
1670 - 1673.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|